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AROM   Artificial Rupture of membranes 
C.I    Confidence Interval 
CTG    Cardiotocography 
DUFRHM   Doppler Ultrasound Fetal Heart Rate Monitor 
FHR(s)   Fetal Heart Rate(s) 
IUGR    Intrauterine Growth Restriction 
MOU    Midwife Obstetric Unit 
NVD    Normal vaginal delivery 
ROM    Rupture of membranes 





















Almost four million babies die in the first four weeks of life per year 
worldwide, most from preventable causes. In addition a million babies die 
during labour and delivery (Lawn J et al., 2005).  In South Africa, 
‘intrapartum hypoxia and birth trauma’ are among the top three causes of 
perinatal deaths.  
 
Severe intrapartum hypoxia is often preventable with appropriate maternal 
and fetal monitoring in labour. However, this remains a challenge in under- 
resourced settings, due to difficulties that accompany the use of a Pinard 
Fetal Stethoscope (PFS) which include user-dependence and lack of evidence 
based standardisation in taking measurements with it. Although intermittent 
fetal heart monitoring is as effective as continuous electronic monitoring in 
low risk labours (Banta DH and Thacker, 2001), the search is for reliable, 
robust and cheaper fetal monitoring devices. The innovative crank powered 
Doppler Ultrasound Fetal Heart Rate Monitor (DUFHRM) developed by 
Power-free Education and Technology is robust, cheaper and designed for 










Page | 8  
 
replaceable batteries, and overcomes some of the challenges that come with 




The aim of the study was to assess the accuracy of Fetal Heart Rates (FHRs) 
taken with the DUFHRM compared to FHRs taken with a PFS using a 




This was a comparative diagnostic study conducted at Mowbray Maternity 
Hospital, a public sector maternity hospital in Cape Town during 2012. 
Women with singleton pregnancies in the active phase of the first stage of 
labour, who had consented to participation, were enrolled in the study.  
 
Paired readings of FHRs were taken with a DUFHRM and a PFS, by two 
midwives and also with a CTG during the active phase of the first stage of 
labour before and after two preferably consecutive uterine contractions. The 
midwives were blinded to the CTG measurements by silencing the CTG and 
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a 60 second period in accordance with the guidelines from professional 
bodies (ACOG, 1995, RANZCOG, 2002, RCOG, 2001a, Liston R et al., 2002) 
The DUFHRM and CTG readings were made at the start and end of each 60 
second period of PFS monitoring.  
 
The proportion agreement of FHRs taken with a DUFHRM to FHRs recorded 
with a CTG, and the proportion agreement of FHRs taken with a PFS to 
FHRs recorded with a CTG were determined and compared using McNemar 
Exact Significance Probability test (mcc). The protocol was approved by the 





Seventy six pregnant women with singleton pregnancies in the active phase 
of the first stage of labour were enrolled in the study. The mean age of 
women enrolled was 24 years. Thirty nine women (51.3%) were 
multigravida. Sixty seven women (88.2%) were in labour at term. Sixty six 
women (86.9%) went into spontaneous labour. Labour was augmented in 32 
women. Seventy two women had no medical conditions. Thus the majority 
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Before the first contraction, the proportion agreement to CTG, at the start and 
at the end of the 60 second period, was 0.605 (95% CI 0.486 – 0.715) with the 
DUFHRM and 0.355 (95% CI 0.248 – 0.473) with a PFS (mcc =0.0034) and 
again 0.802 (95% CI 0.695 – 0.885) with the DUFHRM and 0.368 (95% CI 0.260 
- 0.486) with a PFS (mcc = 0.000). 
 
After the first contraction, the proportion agreement to CTG, at the start and 
at the end of the 60 second period, was 0.657 (95% CI 0.540 –0.762) with the 
DUFHRM and 0.421 (95% CI 0.308 – 0.539) with a PFS (mcc =0.0079) and 
again 0.789 (95% CI 0.680 – 0.874) with the DUFHRM and 0.381 (95% CI 0.272 
– 0.500) with a PFS (mcc = 0.000).  
 
Before the second contraction, the proportion agreement to CTG, at the start 
and at the end of the 60 second period, was 0.506 (95% CI 0.388 –.0.624) with 
the DUFHRM and 0.440 (95% CI 0.325 – 0.559) with a PFS (mcc =0.511) and 
again 0.773 (95% CI 0.662 -.0.862) with DUFHRM and 0.506 (95% CI 0.388 – 
0.624) with a PFS (mcc = 0.001). 
 
 After the second contraction, the proportion agreement to CTG, at the start 
and at the end of the 60 second period, was 0.546 (95% CI 0.427 – 0.662) with 
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again 0.773 (95% CI 0.618 – 0.828) with the DUFHRM and 0.480 (95% CI 0.363 




The DUFHRM, compared with a CTG in assessing FHRs both before and 
after uterine contraction in singleton pregnancies in the active phase of the 
first stage of labour, performed significantly more accurately than a PFS. This 
study provides strong evidence for the routine use of a DUFHRM rather than 
a PFS for assessing FHRs before and after uterine contractions in relatively 
low risk pregnancies. This finding promises to improve the quality of 

















Page | 12  
 




Almost four million babies die in the first four weeks of life per year 
worldwide, most from preventable causes. In addition a million babies die 
during labour and delivery (Lawn J et al., 2005). Of the global causes of 
neonatal deaths, 23 per cent are caused by acute intrapartum events, 
specifically fetal hypoxia (Lawn J et al., 2005). Furthermore 30 per cent of 
stillbirths occur during labour and delivery, presumably due to fetal 
hypoxia. Many survivors have varying degrees of brain damage due to fetal 
hypoxia. 
 
In South Africa, ‘intrapartum hypoxia and birth trauma’ are among the top 
three causes of perinatal deaths. The vast majority of these deaths are from 
intrapartum hypoxia as birth trauma is uncommon. The other two common 
causes being spontaneous preterm labour and placental disease (namely pre- 
eclampsia and placental abruption) accounting for 23 per cent each 
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In the vast majority of cases of perinatal mortality, at least one avoidable 
factor can be identified, and these are often related to medical personnel 
(Pattinson RC et al., 1995, Ross M et al., 2002, Van Coeverden de Groot HA 
and Howland, 1984). Of these personnel-associated avoidable neonatal 
deaths, ‘intrapartum fetal distress not detected in fetuses that were being 
monitored in labour’ accounted for 11.5 per cent of all neonatal deaths 
(Pattinson, 2009). This finding was largely attributed to inadequate fetal 
monitoring in labour.  
 
Since early in the nineteenth century when de Kergeradee suggested that 
listening to the fetal heartbeat might be clinically useful to detect fetal 
compromise from variations in the fetal heart rate (Grant, 1989a), various 
methods of listening to the fetal heart have been developed and introduced 
in maternity care. The fetal heart can be monitored either intermittently at 
regular intervals during labour or continuously. The following methods are 
commonly used:  
 
1. Pinard Fetal stethoscope (PFS): this is a cone shaped device. It is cheap 
(costs less than ZAR50) and so widely used for intermittent 
auscultation of the fetal heart. However it requires a fair amount of 
skill and experience. It can be a source of discomfort to the women on 
which it is being used especially during uterine contractions. There is 
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should be auscultated for at least 60 second (RCOG, 2001a, Liston R et 
al., 2002).  
 
2. Hand-held Doppler ultrasound device: there are various types of 
hand-held Doppler devices. These are portable electronic devices and 
are used for intermittent monitoring of the fetal heart. They display a 
fetal heart rate when a Doppler ultrasound transducer is placed on the 
abdomen of a pregnant woman. They are user friendly, can be 
powered by replaceable batteries or mains electricity and they are 
comfortable for the woman. The currently available hand-held 
Doppler ultrasound costs about ZAR5000. 
 
 
3. Cardiotocography (CTG): this device electronically records fetal heart 
and uterine contractions on a paper trace. It uses a Doppler 
ultrasound transducer to monitor fetal heart and a pressure 
transducer to monitor uterine contractions. These are linked to a 
recording machine. The fetal heart can also be monitored with the use 
of a scalp electrode attached to the fetal head. This use is however 
limited by increased prevalence of infectious diseases like Human 
Immunodeficiency Virus and Hepatitis. A CTG can be used 
intermittently or continuously in labour. However it limits mobility of 
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transducers are applied to the pregnant woman’s abdomen during 
labour. A CTG requires electric power and skilled users and well 
trained staff for interpretation. It is also expensive costing up to about 
ZAR30000. Its use was associated with reduction in neonatal seizures, 
increased rates of operative deliveries and Caesarean section but with 
no reduction in perinatal mortality(Alfirevic Z et al., 2008). 
 
4. Other forms of fetal monitoring are classed as ‘electronic’ e.g. Fetal 
electrocardiogram, Fetal pulse oximetry. These are unavailable in 
most maternity units and their clinical usefulness is still an area of 
extensive research. 
 
In South Africa, the majority of births occur in community health centres and 
district hospitals(Pattinson, 2009). These are usually under- resourced 
settings where staffing is often inadequate and personnel are involved in 
multiple tasks. Most fetal monitoring is done intermittently with a PFS. Most 
intrapartum, neonatal and maternal deaths occur in these facilities. 
 
Severe intrapartum hypoxia is often preventable with appropriate maternal 
and fetal monitoring in labour. However, this remains a challenge in under- 
resourced settings, more so with difficulties that accompany the use of a PFS. 
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Goal which is to reduce by two-thirds the number of deaths under 5 years of 
age between 1990 and 2015. 
 
 
1.2. Rationale of the study 
 
Effective intrapartum monitoring is needed to reduce perinatal and maternal 
morbidity, and save fetal, neonatal and maternal lives. Currently available 
devices for continuous intrapartum fetal monitoring are not affordable or 
sustainable in most low resource settings. They are also not recommended in 
low risk labours as intermittent fetal heart monitoring is as effective as 
continuous electronic monitoring in these low risk labours (Banta DH and 
Thacker, 2001).  In South Africa, it is recommended that a Pinard Fetal 
Stethoscope or preferably a hand-held Doppler device is used for low risk 
labours and Cardiotocography is used for high risk labours (Department of 
Health, 2007, Ferrell E, 2005). However due to scarcity of hand-held Doppler 
devices due to cost, intermittent monitoring is performed, almost always 
with a PFS in low resource settings.  
 
The PFS is cheap and widely available. However, in most of the low resource 
settings, a midwife has multiple tasks to fulfil simultaneously making it 
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Furthermore although there is no empirical evidence on the optimal 
frequency of intermittent auscultation, there is a consensus that the fetal 
heart should be auscultated at least every 15 minutes in the first stage of 
labour and at least every 5 minutes in the second stage of labour (ACOG, 
1995, Liston R et al., 2002, RANZCOG, 2002, RCOG, 2001a) with each 
auscultation lasting at least 60 seconds (Liston R et al., 2002, RCOG, 2001a). 
In South Africa, it is recommended that intermittent fetal monitoring is 
performed every 2 hours in latent phase of the first stage of labour and every 
30 minutes after a contraction in active phase of the first stage of labour, 
preferably with a hand-held Doppler device, in low risk labours (Ferrell E, 
2005). This is challenging for midwives, who have multiple tasks, to use a 
PFS appropriately. This leaves most midwives resorting to ‘listening to a fetal 
heart for a few seconds and simply multiplying by a factor to get a minute 
rate’ as shown by anecdotal reports. The accuracy of counting the fetal heart 
rate with a PFS is also user-dependent. There is also lack of evidence based 
standardisation in taking measurements with it as it appears that 
auscultation protocols were developed initially in the context of clinical trials 
and were based on ‘common sense’ rather than research evidence (Alfirevic 
Z et al., 2008).  
 
Given the difficulty and limitations in the use of a PFS for the healthcare 
worker and the discomfort for the mother in a busy midwife obstetric unit, 
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is as safe as continuous electronic monitoring in low risk labours (Banta DH 
and Thacker, 2001), this may not be the case where correct auscultation with 
a PFS is not done.  
 
In under-resourced settings, a hand held Doppler ultrasound fetal heart rate 
monitor is the most promising method of effective intermittent monitoring. 
A randomised trial in Zimbabwe enrolled 1255 women who were 37 weeks 
or more pregnant with singleton pregnancy and normal fetal heart rate 
before study entry. Women were randomised to intermittent intrapartum 
fetal monitoring by electronic monitoring, Doppler ultrasound, use of Pinard 
stethoscope by a research midwife or routine use of Pinard stethoscope by 
attending midwife. Abnormalities in fetal heart rate were more reliably 
detected by a Doppler ultrasound than with a Pinard Stethoscope and its use 
resulted in good perinatal outcome (Mahomed K et al., 1994). In a 
prospective study to assess the preference of women for fetal monitoring 
with a Pinard stethoscope, innovative wind-up Doppler ultrasound fetal 
heart rate monitor and cardiotocography, significantly more women 
preferred the innovative wind-up Doppler ultrasound fetal heart rate 
monitor to the other 2 methods (Mangesi L et al., 2009). However there are 
concerns regarding currently available hand-held Doppler devices and the 
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settings because of cost and need for replaceable batteries or mains 
electricity.  
 
Power-free Education and Technology, a South African registered non-profit 
organisation, overcame these obstacles and developed a wind- up DUFHRM. 
This DUFHRM is powered by winding a hand crank and does not need 
replaceable batteries or charging with mains electricity. It is also cheaper 
(costing about ZAR1500) than the available hand-held Doppler ultrasound 
fetal heart rate monitors. The device uses an obstetric ultrasound probe 
connected to the main unit by a cord. The main unit processes the signal and 
displays it. 
 
Initial field testing of the DUFHRM was conducted in 17 women in various 
stages of labour. Simultaneous pairs of readings of fetal heart rate were 
obtained using DUFHRM and cardiotocography. There was no statistical 
difference between readings from DUFHRM and CTG. In a survey of 97 
mothers by the same authors, 72 (74%) preferred the DUFHRM to CTG or 
PFS as fetal monitoring tool (Bezuidenhout H et al., 2006). However, studies 
on comparison of performance of currently available hand-held Doppler 
devices to PFS in clinical settings are sparse. Furthermore there are no 
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The CTG was chosen for use as the standard intrapartum fetal monitoring 
device as it is the standard fetal heart monitor used in secondary and tertiary 
level hospitals in Western Cape, South Africa. Ancillary tests such as fetal 
blood sampling and testing are only done under special circumstances. 
Clinical decisions for suspected fetal compromise in labour are largely based 
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There is no difference in the accuracy of the DUFHRM and PFS in 
determining the fetal heart rate before and after contractions in labour when 
compared to the fetal heart rate measured by a CTG. 
 
2.2. Primary Objective 
 
To assess whether the DUFHRM is more accurate than a PFS in 
determining fetal heart rates, before and after uterine contraction, in 
labour when compared to a CTG.  
 
2.3. Secondary objectives 
 
2.3.1. Determine the proportion agreement of FHRs obtained with the 
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2.3.2 Determine the proportion agreement of FHRs obtained with a 
PFS to FHRs recorded with a CTG before and after a contraction. 
 
2.3.3 Compare the proportion agreement of FHRs obtained with 
DUFHRM to FHRs recorded with a CTG, to the proportion agreement 
of FHRs obtained with PFS to FHRs obtained with a CTG.  
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CHAPTER 3   METHODOLOGY 
 
3.1. Study design 
 
This was a comparative diagnostic study to assess accuracy of a DUFHRM 
and PFS when compared to a CTG in assessing the FHRs before and after 
contractions in singleton pregnancies during the active phase of the first 
stage of labour.  
 
3.2. Study site and population 
 
The study was conducted at Mowbray Maternity Hospital in Cape Town, 
South Africa. Mowbray Maternity Hospital is a public sector secondary level 
maternity hospital that provides maternal and newborn healthcare services 
for the local community requiring state health care and also receives referral 
cases from the following state primary level midwife obstetric units (MOU) 
within its catchments area: Khayelitsha, Gugulethu, and Mitchell’s Plain 
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3.3. Sample size 
 
Sample size was calculated to show with 95% confidence whether FHRs 
taken with a DUFHRM were at least 95% as accurate as FHRs recorded with 
a CTG. The risk of a DUFHRM not being as accurate as a CTG was accepted 
to be 20%. Thus with α = 0.05 and β= 0.2, sample size was estimated to be 75 
women. 
 
3.4. Recruitment and Enrolment of participants 
 
Pregnant women admitted to the labour ward of Mowbray Maternity 
Hospital in the active phase of the first stage of labour, and meeting the 
study inclusion criteria, were approached by the two research midwives or 
the study investigator for recruitment and enrolment into this study. The 
consent forms were administered by the research midwives or the study 
investigator. Pregnant women meeting the following study criteria were 
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3.4.1. Inclusion criteria 
 
3.4.1a. Women with singleton pregnancies in the active phase 
of the first stage of labour undergoing continuous CTG 
monitoring. This included women in preterm labour in order to 
allow assessment of a DUFHRM and a PFS in detecting late 
decelerations which are more prevalent in high risk labours 
than low risk labours. 
 
3.4.1b. Women with singleton regnancies in the active phase 
of the first stage of labour who were undergoing continuous 
CTG monitoring and awaiting an emergency caesarean section 
for any indications e.g. failure to progress, failed vaginal birth 
after a previous Caesarean section, a suspicious or pathological 
CTG tracing. This inclusion criterion was made to include 
women with potential fetal heart rate abnormalities so as to 
allow assessment of a DUFHRM and a PFS in detecting late 
decelerations  
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3.4.2. Exclusion criteria 
 
3.4.2a. Women with multiple pregnancies 
 
3.4.2b. Women in labour with an intrauterine fetal death or not  
requiring fetal monitoring as assessed by the attending doctor 
(e.g. in very preterm labour with a gestational age below 28 
completed weeks or severe fetal anomalies). 
 
3.4.2c. Women who withdraw informed consent at any time 
during the study. 
 
3.4.2d. Women requiring Caesarean section for an indication 


















On each participant, paired readings of the FHR were taken using a 
DUFHRM and PFS during two, preferably consecutive, uterine 
contractions by two different research midwives. At the same time the 
FHR was noted on the CTG and recorded by the study investigator. 
The two research midwives swapped devices at the second uterine 
contraction. The midwives were blinded to the CTG recording by 
silencing the CTG and turning it aside from their view by the study 
investigator who recorded the CTG FHR readings: 
 
3.4.3a. In pregnant women undergoing continuous CTG 
monitoring, FHRs were recorded by the DUFHRM and PFS 
before a uterine contraction and again 30 seconds after the end 
of the uterine contraction while in the active phase of the first 
stage of labour. 
 
3.4.3b. The fetal heart was listened to for 60 seconds using a PFS 
to obtain a FHR in beats per minute. Considering that the FHR 
obtained by a PFS required listening to the fetal heart for 60 
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seconds of detecting the fetal heart activity, in this study, the 
FHR recorded using the DUFHRM and CTG were obtained 
twice by recording the FHR at the beginning and again at the 
end of the 60 second measurement period of FHR with PFS. 
The midwife using the PFS would indicate when she started 
counting the FHR and when she finished so that corresponding 
readings of the FHR on the CTG and DUFHRM were noted by 
the other observers. 
 
The FHR taken with the PFS and the DUFHRM were considered to be in 
agreement with the FHR recorded by the CTG if it was within 5 beats per 
minute. 
 
National Institute for Health and Clinical Excellence guidelines (NICE, 
September 2007) for CTG interpretation were used to classify the CTG traces 
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Table 1: Classification of FHR features 
Feature Baseline 
FHR (bpm) 
Variability (bpm) Decelerations Accelerations 
Reassuring 110-160 ≥ 5 None Present 
Non-reassuring 100-109 
161-180 




with over 50% of 
contractions, 




up to 3 minutes 
The absence of 
accelerations 
with otherwise 
normal trace is 
of uncertain 
significance 





<5 for 90 minutes Either atypical 
variable 
decelerations 
with over 50% of 
contractions or 
late decelerations, 
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Table 2: Definition of Normal, Suspicious and Pathological CTG traces 
Category Definition 
Normal  A FHR trace in which all four features are classified as reassuring 
Suspicious A FHR trace with one feature classified as non-reassuring and the 
remaining features classified as reassuring 
Pathological  A FHR trace with two or more features classified as non-reassuring 
or one or more classified as abnormal 
 
 
Social, demographic, medical history information and pregnancy outcome 
data were extracted from the mothers’ and the babies’ hospital files after 
delivery. 
 
Neonatal outcomes of pregnancies included gestational age at delivery, birth 
weights, Apgar scores at 1 and 5 minutes after birth, need for resuscitation, 
admission to the neonatal intensive care unit and baby alive on discharge of 
the mother from the hospital. 
 
The data collection sheet, standard operating procedures used for the study, 
as well as the three fetal heart rate monitoring devices compared, are shown 
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3.5. Quality control 
 
The FHR measurements taken with a PFS and the DUFHRM were done by 
two very experienced midwives who had been recruited as research 
midwives. Thus they were already trained in the use of a PFS. However, they 
still underwent re-training with the use of a PFS and the DUFHRM before 
they started taking FHR measurements on the study participants. A standard 
operating procedure was also prepared and adhered to during conduct of the 
study (Appendix 10.4). The research midwives were verseen by the 
investigator who is a registrar in the department of Obstetrics and 
Gynaecology at the University of Cape Town.   
 
Random checks were done on non-study participants to make sure that the 
DUFHRM was working properly. The measurements taken in the study were 
double entered on the database using Epidata version 3.1 in order to 
minimise data entry errors before analysis. The database was also designed 
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3.6. Pilot study 
 
A pilot study was done on 5 women in each of the CTG trace categories i.e. 
normal and suspicious or pathological CTG. This allowed planning for the 
actual study data collection and anticipation of potential problems that might 
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CHAPTER 4   STATISTICAL CONSIDERATIONS AND DATA 
ANALYSIS 
 
Data were entered on a database generated on Epidata version 3.1 and 
converted into Microsoft Excel 2012 and later transferred into the Statistical 
Package for Social Sciences version 2011 (SPSS 2011) for data analysis. 
 
Descriptive analysis of the participants’ socio-demographic characteristics 
was done. This included frequencies of age distribution, gravidity, parity, 
medical history and obstetric risk factors of the enrolled women. 
 
The proportion of CTG categories as per NICE guidelines (i.e. normal, 
suspicious and pathological CTG) was determined. Proportion agreement 
and 95% confidence intervals of the proportion agreements between FHR 
measurements taken with a DUFHRM to the FHR recorded with a CTG, and 
also between FHR measurements taken with a PFS to FHRs recorded with a 
CTG were determined and compared. The FHR taken with a PFS and the 
DUFHRM were considered to be in agreement with the FHR recorded by 
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Statistical significance of the proportion agreement of the FHR obtained with 
the DUFHRM to a CTG and proportion agreement of the FHR obtained with 
a PFS to a CTG was done using the Exact McNemar significance probability 
test as the proportions were independent of each other. Significance 
difference of the proportion agreements compared was considered at Exact 
McNemar significance probability of less than 0.05. Before and after each 
uterine contraction there were two FHR readings with DUFHRM and two 
FHR readings with CTG for each FHR reading with PFS as the other devices 
were used at the start and at the end of the 60 second measuring period with 
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CHAPTER 5   ETHICAL CONSIDERATIONS 
 
The research protocol was submitted for approval to the University of Cape 
Town, Department of Obstetrics and Gynaecology research committee before 
submission to the University of Cape Town, Faculty of Health Sciences 
Research Ethics Committee. Both committees approved the study before it 
was conducted. 
 
The management of Mowbray Maternity Hospital was approached for 
approval that the study be conducted at the site and approval was granted 
accordingly. A written informed consent was sought from potential study 
participants. Only participants who had the ability and willingness to 
provide a written informed consent were enrolled in the study. Mowbray 
Maternity Hospital translators/ interpreters were asked by the research 
midwives or the investigator to translate/interpret the consent to 
participants who could not speak and/or read English. The informed consent 
form is included in Appendix 10.1 
 
To avoid undue pressure on the potential participants, recruitment and 
enrolment were done once the women had been attended to and admitted by 
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sure or needed to discuss with their family members before agreeing to 
participation in the study were allowed to consult their family. The written 
informed consent was obtained by the trained research midwife or the study 
investigator.  
 
Any study procedure or activity was not done if there was any need for 
urgent intervention in the care of the potential participants.  Data collection 
forms were kept separate from the signed written informed consent forms. 
Names of enrolled participants and participant hospital folder numbers were 
linked in a separate name link log. All these documents were only accessible 
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CHAPTER 6  RESULTS 
 
6.1a. Socio-demographic characteristics  
 
We enrolled 76 women with singleton pregnancies in the active phase of the 
first stage of labour. Of these, 4 women were awaiting caesarian section. The 
mean age of the women enrolled was 24 years.  Thirty seven (48.7%) of the 
enrolled women were primigravida and 39 women (51.3%) were 
multigravida. Sixty seven women (88.2%) were in labour at term (i.e. 37 
completed weeks or more) and 9 (11.8%) had preterm pregnancies (Table 3). 
 
Twenty five women (32.9%) were married and 72 (94.5%) women were 
unemployed. Smoking, alcohol and use of other substances were reported in 
18 (23.7%), 11 (14.5%) and 2 (2.6%) respectively. Three women (3.9%) were 
asthmatic and 1 woman (1.3%) had epilepsy while the rest had no other 
medical conditions. Obstetric risk factors identified among the women were: 
previous Caesarean section in 5 (6.5%); gestational hypertension in 6 (7.8%); 
pre-eclampsia in 2 (2.6%); postdate pregnancy(Hall, 2011) in 13 (17.1%), 
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Table 3 : Socio-demographic characteristics 
Total number of participants: 76 pregnant women                                                             
Maternal Age (years)      Mean (SD)       24 (6)                        
Maternal Age range (years)                     13-38 
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Obstetric risk factors 







































   
 
6.1b. Details of current labour  
 
Table 4 shows details of the current labour of the enrolled women. Sixty six 
women (86.9%) went into spontaneous labour and 10 women (13.1%) had 
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augmentation of labour was by artificial rupture of membranes and in 7 
women (9.2%), labour was augmented by oxytocin  
 
The indications for induction of labour were postdate pregnancy in 4 women 
(36.3%); gestational hypertension in 4 women (36.3%); prolonged rupture of 
membranes in 1 woman (9%), pre-eclampsia in 1 woman (9%); 
oligohydramnios in 1 woman (9%). One woman had both postdate 
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Table 4: Labour details 
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6.2. Fetal heart rate measurements 
 
Data for fetal heart rate measurements were available for 76 women at the 
time of the first uterine contraction and for 75 women at the time of second 
uterine contraction. At the time of fetal heart rate measurements taken in this 
study, 43 women (56.6%) had a normal CTG trace, 24 women (31.6%) had a 
suspicious trace and only 9 women (11.8%) had a pathological CTG trace 
(Table 4). 
 
6.2.1 The proportion agreements before and after first contraction by CTG 
category. 
 
Table 5 shows the proportion agreements of FHRs obtained by the DUFHRM 
to FHRs recorded with a CTG compared with the proportion agreements of 
FHRs obtained by a PFS to FHRs recorded with a CTG, done before and after 
the first contraction by CTG category. The proportion agreements of FHRs 
obtained by the DUFHRM to FHRs recorded with a CTG are consistently 
higher than proportion agreements of FHRs obtained by a PFS to FHRs 
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Table 5: The proportion agreement of FHRs obtained by DUFHRM to FHRs recorded with 
CTG compared with proportion agreement of FHRs obtained by PFS to FHRs recorded with 
CTG done before and after the first contraction by CTG category 





Number of participants                      9 
Before 
contraction 
       24         43 
DUFHRM/CTG1 0.778 0.625 0.556 
PFS/CTG 1                                       0.333 0.250                                 0.419
 
DUFHRM/CTG 2                              0.889 0.667                                 0.860





DUFHRM/CTG 1                              0.667 0.791                                   0.581
PFS/CTG 1                                        0.556 0.208                                   0.512
    
DUFHRM/CTG 2                               0.667 0.792                                  0.814
PFS/CTG 2                                         0.556 0.250                                  0.419
DUFHRM/CTG 1= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
a CTG at the start of 60 second FHR measurement period with PFS; PFS/CTG 1= proportion 
agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG at the 
start of 60 second FHR measurement period with PFS);  
DUFHRM/CTG 2= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
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agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG taken 
at the end of 60 second FHR measurement period with PFS) 
 
 
6.2.2 The proportion agreements before and after second contraction by CTG 
category 
 
Table 6 shows the proportion agreements of FHRs obtained by the DUFHRM 
to FHRs recorded with a CTG compared with the proportion agreements of 
FHRs obtained by a PFS to FHRs recorded with a CTG, done before and after 
second contraction by CTG category. Before the second contraction, the 
proportion agreement to FHRs recorded with a CTG, at the start of 60 second 
measuring period, was 0.222 with the DUFHRM and 0.556 with a PFS for a 
pathological CTG tracing, 0.522 with the DUFHRM and 0.435 with a PFS for 
a suspicious CTG tracing, 0.558 with the DUFHRM and 0.419 with a PFS for a 
normal CTG tracing. After the end of the second contraction, the proportion 
agreement to FHRs recorded with CTG, at the end of the 60 second 
measuring period, was 0.814 with the DUFHRM and 0.512 with a PFS for a 
normal CTG tracing, 0.652 with the DUFHRM and 0.435 with a PFS for a 
suspicious CTG and 0.556 with the DUFHRM and 0.444 with a PFS for a 
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The proportion agreement of FHRs obtained by the DUFHRM to the FHRs 
obtained by CTG at the start of 60 second FHR measurement period with PFS 
for the pathological CTG category in tables 5 and 6 were 0.778 and 0.222 
respectively. Likewise the proportion agreements of FHRs obtained by PFS 
to FHRs obtained by CTG at the start of the 60 second FHR measuring 
period, PFS/CTG1, were 0.333 and 0.556 respectively in the same tables. 
Similar large discrepancies in proportion agreements were noted in the 
suspicious CTG category for the proportion agreements of FHRs obtained by 
PFS to FHRs obtained by CTG at the start of the 60 second FHR measuring 
period, PFS/CTG1 and also in the proportion agreements of FHRs obtained 
with PFS to FHRs recorded with CTG taken at the end of 60 second FHR 
measurement period with PFS, when compared at the first and second 
uterine contractions. In contrast, the respective proportion agreements were 
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Table 6: The proportion agreement of FHRs obtained by DUFHRM to FHRs recorded with 
CTG compared with proportion agreement of FHRs obtained by PFS to FHRs recorded with 
CTG done before and after second contraction by CTG category 





Number of participants        9                                  
Before contraction 
24                              43
DUFHRM/CTG1 0.222 0.522 0.558 
PFS/CTG 1                                       0.556 0.435                                 0.419
 
DUFHRM/CTG 2                              0.778 0.652                                  0.837
PFS/CTG 2                                        0.778 1.000                                 0.488
 After Contraction   
DUFHRM/CTG 1                              0.667 0.435                                   0.581
PFS/CTG 1                                        0.556 0.435                                   0.512
    
DUFHRM/CTG 2                               0.556 0.652                                 0.814
PFS/CTG 2                                         0.444 0.435                                  0.512
DUFHRM/CTG 1= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
a CTG at the start of 60 second FHR measurement period with PFS; PFS/CTG 1= proportion 
agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG at the 
start of 60 second FHR measurement period with PFS);  
DUFHRM/CTG 2= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
a CTG at the end of 60 second FHR measurement period with PFS ;PFS/CTG 2= proportion 
agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG taken 
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6.2.3 The proportion agreements before and after first contraction for all CTG 
categories 
 
Table 7 shows the proportion agreements of FHRs taken with the DUFHRM 
to FHRs recorded with a CTG compared with the proportion agreements of 
FHRs taken with a PFS to FHRs recorded with a CTG before and after first 
contraction for all CTG categories. The data were available for all 76 enrolled 
women. 
 
Before the first contraction, the proportion agreement to CTG was 0.605 (95% 
CI 0.486 – 0.715) with the DUFHRM and 0.355 (95% CI 0.248 – 0.473) with a 
PFS, at the start of the 60 second measuring period, and 0.802 (95% CI 0.695 – 
0.885) with the DUFHRM and 0.368 (95% CI 0.260 – 0.486) with a PFS, at the 
end of the 60 second measuring period. The proportion agreement of the 
DUFHRM to a CTG was statistically significantly different from the 
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Table 7: The Proportion agreement of FHRs obtained by DUFHRM to FHRs recorded with 
CTG compared with proportion agreement of FHRs obtained by PFS to FHRs recorded with 
CTG before and after first contraction for all CTG categories 




       95% CI       mcc 
  Before 
contraction 
  
DUFHRM/CTG1 76 0.605 0.486-0.715  
PFS/CTG 1                                       76 0.355                                  0.248-0.473    
 
0.0034 
DUFHRM/CTG 2                              76 0.802                                  0.695-0.885  
PFS/CTG 2                                        76 0.368                                  0.260-0.486    0.00 
  After 
Contraction 
  
DUFHRM/CTG 1                              76 0.657                                   0.540-0.762  
PFS/CTG 1                                        76 0.421                                   0.308-0.539     0.0079 
     
DUFHRM/CTG 2                               76 0.789                                  0.680-0.874  
PFS/CTG 2                                         76 0.381                                  0.272-0.500    0.00 
DUFHRM/CTG 1= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
a CTG at the start of 60 second FHR measurement period with PFS; PFS/CTG 1= proportion 
agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG at the 
start of 60 second FHR measurement period with PFS); DUFHRM/CTG 2= proportion agreement of 
FHRs obtained with DUFHRM to FHRs recorded with a CTG at the end of 60 second FHR 
measurement period with PFS; PFS/CTG 2= proportion agreement of FHRs obtained with PFS to 
FHRs recorded with CTG (FHRs recorded with CTG at the end of 60 second FHR measurement 











Page | 49  
 
After the first contraction, the proportion agreement to a CTG was 0.657 (95% 
CI 0.540 – 0.762) with the DUFHRM and 0.421 (95% CI 0.308 – 0.539) with a 
PFS, at the start of the 60 second measuring period, and 0.789 (95% CI 0.680 – 
0.874) with the DUFHRM and 0.381 (95% CI 0.272 – 0.500) with a PFS, at the 
end of the 60 second measuring period. The proportion agreement of the 
DUFHRM to a CTG was statistically significantly different from the 
proportion agreement of a PFS to a CTG (mcc = 0.0079 and mcc = 0.00) (Table 
7). 
 
6.2.4 The proportion agreements before and after second contraction for all 
CTG categories 
 
Before the second contraction, the proportion agreement to a CTG was 0.506 
(95% CI 0.388 – 0.624) with the DUFHRM and 0.440 (95% CI 0.325 – 0.559) 
with a PFS, at the start of the 60 second measuring period, and 0.773 (95% CI 
0.662 – 0.862) with the DUFHRM and 0.506 (95% CI 0.388 – 0.624) with a PFS, 
at the end of the 60 second measuring period. The proportion agreement of 
the DUFHRM to a CTG was statistically significantly different from the 
proportion agreement of a PFS to a CTG for FHRs taken at the end of the 60 
second measuring period with a PFS (mcc= 0.001) and not statistically 
different for the FHRs taken at the start of 60 second measuring period with a 
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Table 8: The proportion agreement of FHRs obtained by DUFHRM to FHRs recorded with 
CTG compared with proportion agreement of FHRs obtained by PFS to FHRs recorded with 
CTG before and after second contraction for all CTG categories 




     95% CI     mcc 
  Before 
contraction 
  
DUFHRM/CTG1 75 0.506                                  0.388-0.624  
PFS/CTG 1                                       75 0.440                                  0.325-0.559    
 
0.511 
DUFHRM/CTG 2                              75   0.773                                  0.662-0.862  
PFS/CTG 2                                        75 0.506                                  0.388-0.624    0.001 
  After 
Contraction 
  
DUFHRM/CTG 1                              75     0.546                                  0.427-0.662  
PFS/CTG 1                                        75   0.493                                  0.375-0.611   0.651 
     
DUFHRM/CTG 2                               75    0.773                                  0.618-0.828  
PFS/CTG 2                                         75 0.480                                  0.363-0.598    0.001 
DUFHRM/CTG 1= proportion agreement of FHRs obtained with DUFHRM to FHRs recorded with 
a CTG at the start of 60 second FHR measurement period with PFS; PFS/CTG 1= proportion 
agreement of FHRs obtained with PFS to FHRs recorded with CTG (FHRs recorded with CTG taken 
at the start of 60 second FHR measurement period with PFS); DUFHRM/CTG 2= proportion 
agreement of FHRs obtained with DUFHRM to FHRs recorded with a CTG at the end of 60 second 
FHR measurement period with PFS; PFS/CTG 2= proportion agreement of FHRs obtained with PFS 
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measurement period with PFS; mcc = Exact McNemar significance probability, C.I = Confidence 
Interval  
 
After the second contraction, the proportion agreement to CTG was 0.546 
(95% CI 0.427 – 0.662) with the DUFHRM and 0.493 (95% CI 0.375 – 0.611) 
with a PFS, at the start of the 60 second measuring period, and 0.773 (95% CI 
0.618 – 0.828) with the DUFHRM and 0.48 (95% CI 0.363 – 0.598) with a PFS, 
at the end of the 60 second measuring period. The proportion agreement of 
the DUFHRM to a CTG was statistically significantly different from the 
proportion agreement of a PFS to a CTG for FHRs taken at end of 60 second 
measuring period (mcc =0.001) and not statistically different for the FHRs 
taken at the start of the 60 second measuring period after first contraction 
(mcc = 0.651) (Table 8). 
 
The DUFHRM gave significantly more comparable FHRs to a CTG than a 
PFS at 6 out of 8 time point measurements of FHRs. 
 
6.3. Pregnancy outcomes 
 
Of the enrolled participants, 46 women (63.2%) progressed to normal vaginal 
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(1.3%) required an assisted vaginal delivery with a vacuum extractor (Table 
9). 
 
The birth weight range of babies born to enrolled women was 1520 – 4555 
grams. 72 babies (94.74%) born had birth weight of at least 2500 grams and 
only 4 (5.26%) had birth weight less than 2500 grams. No baby was born with 
an Apgar score of below 7 at 1 minute and 5 minutes after delivery. Only one 
baby was admitted to the neonatal intensive care unit. This baby was 
preterm, born to a mother who had no antenatal care and the baby’s birth 
weight was 1520grams. All babies born were alive at the time of the mother’s 
discharge from hospital (Table 9). One baby required some resuscitation for 
poor respiratory effort after birth by vacuum extraction. Of the 9 women who 
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Table 9: Pregnancy outcomes for 76 enrolled women 
Characteristic Number Percentage  
Mode of delivery    








Birth weight range 1520-4555grams    
2500 or more grams 72 94.7  




Apgar score less than 7 at 1 minute 
Apgar score less than 7 at 5minutes 
 
Neonatal resuscitation done 
Admission to NICU 
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CHAPTER 7   DISCUSSION 
 
This study showed that the DUFHRM was more accurate than a PFS in 
assessing the FHR in singleton pregnancies in the active phase of the first 
stage of labour when compared to a CTG as a standard intrapartum fetal 
monitoring device. In this study, 67 of the women (88.2 %) enrolled had term 
pregnancies with only 9 (11.8%) preterm. Most women had no medical 
problems, 66 women (86.9%) went into spontaneous labour and only 10 
women required induction of labour. This reflects the low risk status of the 
study population on which the devices were tested in assessing FHR in 
labour. Twenty seven women (35.5%) delivered by caesarean section. 
However this caesarian section rate was inflated by referral bias and 
including the normal deliveries at the referring MOUs would result in a 
much lower rate, thus reflecting the low risk nature of the study population. 
The low risk nature of the study population was also reflected in the high 
percentage of babies weighing 2500 grams or more (94.7%), no babies born 
with low Apgar scores and only 1 baby needing admission to the neonatal 
intensive care unit.  
 
The study population reflected pregnancies that would meet criteria for 
intermittent fetal heart rate monitoring. As expected for low risk 
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women (31.6%) and 9 women (11.8%) having a suspicious and pathological 
CTG trace respectively. This was therefore an appropriate population for 
testing the comparability of the DUFHRM and a PFS to a CTG for assessing 
fetal heart rate in relatively low risk labours where intermittent fetal 
monitoring would be appropriate. Intermittent fetal heart monitoring is as 
effective as continuous electronic monitoring in such low risk labours.  
 
The DUFHRM gave significantly more comparable FHRs to a CTG than a 
PFS at 6 out of 8 time point measurements of FHRs. This was not surprising 
considering that the DUFHRM uses the same basic principle, the Doppler 
effect, which the cardiotocography uses to measure FHRs. It also recorded 
the measurement of FHR at the same time and displays the heart rate. It may 
be argued that the comparability of PFS to CTG was compromised by 
continuous use of CTG throughout the time that FHR readings were taken 
with PFS in contrast to typical use of PFS where the abdomen of women is 
free from any CTG probes and their supporting elastic bands. However, FHR 
readings with DUFHRM were also taken with CTG monitoring in progress. 
This study did not assess formally the difficulties of use of PFS and 
DUFHRM with the CTG monitoring in progress. Further studies will need to 
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In this study a PFS was used for measuring the FHR over 60 seconds. This is 
in contrast to the typical use of PFS in a busy midwife obstetric unit where 
most midwives count the FHR for 15 seconds only and get the rate by 
multiplying by a factor of 4 (anecdotal reports), which has a  potential for 
error. Thus the proportion agreements of FHRs taken with a PFS to FHRs 
recorded with a CTG in this study might actually have over-estimated the 
accuracy of a PFS compared to a typical clinical setting where a PFS is 
commonly used. We also recruited the services of two well experienced 
midwives who followed standard operating procedures in assessing FHRs 
using both of the fetal heart rate measuring devices (i.e. DUFHRM and PFS). 
This contrasts to the typical use of PFS in a busy midwife obstetric unit 
where often no standard operating procedure for taking the FHR with a PFS 
would be found leaving every midwife to use PFS in a way s/he was taught 
while in nursing school. This potentially brings about significant inter-
individual variation in the FHRs obtained.  
 
In the field study comparing DUFHRM and CTG, Bezuidenhout et al showed 
no significant difference between readings from the DUFHRM compared to 
the CTG (Bezuidenhout H et al., 2006). To date there is no published study 
that compared FHRs taken with the DUFHRM to FHRs recorded with a CTG 
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This study was done in a clinical setting where women were in labour at a 
hospital that also serves women with relatively low risk pregnancies in 
addition to women referred with other obstetric or intrapartum 
complications. It also compared in the most practical way, simultaneous 
measurements of FHRs taken using three devices.   
 
The timing of assessing the FHRs by the DUFHRM and a CTG during the 60 
seconds needed to obtain a FHR with a PFS gives scope to bias. Therefore we 
compared FHRs obtained by the DUFHRM and a PFS with that recorded 
with the CTG at the start and at the end of the 60 second period. Given the 
difficulty in comparing readings taken by PFS which requires a period of 
time (at least 30 seconds) to CTG and DUFHRM which give a FHR reading 
instantly, this design of comparing the 3 devices was the best one arrived at 
with consultation from experts in the field.  
 
We found significantly higher proportion agreements with the DUFHRM 
compared with a PFS, at the start and at the end of the 60 second period, both 
before and after the first uterine contraction. In contrast, we found that the 
proportion agreements of FHRs taken with the DUFHRM to a CTG were 
greater but not significantly different from the proportion agreements of 
FHRs taken with a PFS to a CTG at the start of the 60 second period, both 
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we found significantly higher proportion agreements with the DUFHRM 
compared to a PFS at the end of the 60 second period, both before and after 
the second uterine contraction. There is no obvious explanation as to why the 
proportion agreements should differ in this manner (Table 8).  
 
There were large discrepancies in the proportion agreements, specifically 
DUFHRM/CTG1, PFS/CTG1 and PFS/CTG2 compared at the first and 
second uterine contractions for the pathological CTG category and 
suspicious CTG category. Noteworthy, the respective proportion agreements 
were similar in the normal CTG category for the first and second uterine 
contractions (Tables 5 and 6). The large discrepancies in the proportion 
agreements could be attributed to the smaller numbers of pathological CTG 
traces and suspicious CTG traces compared to normal CTG traces (Table 4). 
It could also be attributable to the large variations in the abnormalities that 
could be observed in the features of CTG e.g. types of decelerations and their 
duration which could vary widely. 
 
This study could not establish with certainty the reliability of the DUFHRM 
in detecting the presence or absence of late decelerations as only 9 women 
had pathological CTG tracings. This was possibly attributable to the high 
proportion of women with relatively low risk pregnancies who were enrolled 
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however have brought about bias as the observer might have suspected a 
pathological CTG as intrauterine resuscitation would have been instituted on 
the participants with pathological or suspicious CTG. Blinding the observers 
by delaying intrauterine resuscitation where CTG tracing was suspicious or 
pathological in order to assess the reliability of these devices to detect late 
decelerations would be unethical as that would mean delaying or denying 
the women standard of care. Thus the only practical way to assess reliability 
of the DUFHRM to detect late decelerations was a chance finding of women 
with late decelerations, again not a common occurrence in low risk 
pregnancies as has been shown in this study population. It would also 
require enrolling large numbers of women to identify possibly enough 
sample study to draw conclusions on. 
 
The DUFHRM also lacks the ability to assess baseline variability of the FHR, 
which is one of the four features of the FHR that the CTG is able to assess. 
For this reason, as well as the continuous nature of the CTG, it is not 
recommended that DUFHRM be the method of choice for fetal assessment in 
labour of high risk pregnancies. 
  
Another limitation in this study was the use of a CTG as the standard fetal 
monitoring device for assessing fetal well-being. It is recognised that while 
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being associated with cerebral palsy, the specificity of a CTG for prediction of 
cerebral palsy is low with reported false positive rates as high as 99.8% even 
in the presence of late decelerations and decreased variability(Nelson KB et 
al., 1996). This was however the best available device used for monitoring 
fetal heart in the setting in which the study was done.  
 
Regardless of the limitations cited above, we demonstrated that the 
DUFHRM compares with a CTG in assessing the FHR in singleton 
pregnancies in labour significantly more accurately than a PFS. This would 
suggest that the DUFHRM would also be more accurate in detecting late 
decelerations and therefore be a preferable method of identifying mothers 
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CHAPTER 8   CONCLUSION 
 
This study documents that the DUFHRM is more accurate than the PFS in 
determining the FHR both before and after uterine contractions in low risk 
pregnancies in the active phase of the first stage of labour. The DUFHRM 
also gives an objective rate rather than relying on the midwife counting the 
FHR over a minute. The data provides strong evidence for the routine use of 
a DUFHRM rather than a PFS for monitoring the FHR during labour in low 
risk singleton pregnancies. This would apply in many district hospitals and 
most clinics where low risk pregnancies are managed in South Africa.  
 
The additional cost of a DUFHRM when compared to cost of a PFS needs to 
be balanced against the more accurate measurement in FHR which forms the 
basis of assessing fetal wellbeing in labour. Improved intrapartum fetal 
monitoring promises to reduce the risk of fresh stillbirths and decrease both 
neonatal morbidity and mortality. 
 
There is need for further research on comparing DUFHRM to CTG in the 
diagnosis of fetal distress if the DUFHRM is to realise the full potential of 
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any difficulties that may come about with use of DUFHRM with CTG 
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CHAPTER 10   APPENDICES 
10.1 Informed consent form 
Consent to Participate in a Research Study  
 
Comparability of an innovative Doppler ultrasound fetal heart rate 
monitor to a Pinard fetal stethoscope using cardiotocography as a standard 
to assess the fetal heart rate in singleton pregnancies during labour at 
Mowbray Maternity Hospital 
 
Principal Investigator: Lameck Chinula, MBBS 
UCT DEPARTMENT: Obstetrics and Gynaecology 
Phone number: (+27) 7 2579 6225 
 
Supervisors:  Prof Susan Fawcus, University of Cape Town 


















You are being asked to volunteer for the research study named above 
because you are or you will be in labour. Dr Lameck Chinula, a registrar in 
the department of obstetrics and gynaecology at the University of Cape 
Town, is in charge of the study supported by Prof Susan Fawcus, Prof 
David Woods and Dr Joy Lawn. Before you decide to be a part of this study 
we want you to know about the study. 
 
This is a consent form. It gives you information about this study.  The 
research staff will talk with you about this information. You are free to ask 
questions about this study at any time.  If you agree to take part in this study, 
you will be asked to sign this consent form.  You will be offered a copy of 
this consent form to keep. 
 
WHY IS THIS STUDY BEING DONE? 
 
The purpose of this study is to see whether your baby’s heart rate, which is 
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with a Doppler ultrasound fetal heart rate monitor or a Pinard stethoscope 
while using the cardiotocography as a standard testing tool.  
 
In low resource settings, cardiotocography monitoring is unavailable and not 
affordable. Most monitoring of the fetal heart is thus done using a Pinard 
stethoscope. There are concerns that fetal heart monitoring using a Pinard 
stethoscope may not be as accurate as using the newly developed Doppler 
ultrasound fetal heart rate monitor. We would like to find out if the new 
monitor is more accurate than a Pinard stethoscope. (Potential participant 
will be shown all the three fetal heart rate monitoring tools mentioned here) 
 
Information obtained in this study may help in recommending the more 
reliable method to use in monitoring FHR of women in labour in low 
resource setting. 
 
WHAT DO I HAVE TO DO IF I AM IN THIS STUDY? 
 
If you decide to join this study, the research staff will ask you to sign a 
written informed consent form. While you are in labour and your baby is 
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listen to the baby’s heart rate using the two different devices. You will be 
subjected to the same management as any other pregnant woman in labour.  
 
HOW MANY PEOPLE WILL PARTICIPATE IN THE STUDY? 
 
A total of at least 75 pregnant women in labour at Mowbray Maternity 
Hospital will participate in this research study. 
 
ARE THERE ANY REASONS WHY YOU CANNOT PARTICIPATE? 
 
You cannot participate if: 
You cannot give a written informed consent 
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WILL YOU BE ASKED TO PAY OR BE PAID ANYTHING TO 
PARTICIPATE? 
 
You will not be paid or asked for payment to participate in the study. No 
penalty will be charged by withdrawing or refusing participation in the 
study.  
 
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS? 
 
Apart from the discomfort of the pressure associated with the use of Pinard 
stethoscope and cardiotocograph, there are no additional risks associated 
with the use of the ultrasound monitor and Pinard stethoscope. 
 
WHAT ARE THE POSSIBLE BENEFITS? 
 
Your baby will be carefully monitored using three devices rather than just 
one device. You and others may benefit in future from what can be learnt in 
this study. You may also be satisfied for participating in this study and 
contributing to knowledge about the accuracy of the newly designed 
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What if you have questions about this study? 
 
If you have questions about the study, contact Dr Lameck Chinula on 
0725796225 or Prof Susan Fawcus 0723354823 or Prof David Woods 
0217865369 
 
What if you have questions about your rights as a participant? 
 
If you have questions about your rights as a study participant, contact the 
University of Cape Town, Faculty of Health Sciences Research Ethics 
Committee, E52 Room 24, Old Main Building, Groote Schuur Hospital, 
















Page | 71  
 
Comparability of an innovative Doppler ultrasound fetal heart rate 
monitor to a Pinard fetal stethoscope using cardiotocography as a standard 
to assess the fetal heart rate in singleton pregnancies during labour at 
Mowbray Maternity Hospital 
SIGNATURES  
If you have understood this information, and you have voluntarily agreed to 
participate in the study, please sign your name or put your mark below. 
____________________                 ________________________            ___________________                  
Participant Name        Participant Signature              Date 
(print) 
____________________ ________________________  
Study Staff Conducting Study Staff Signature                       
Date Consent Discussion (print) 
Participant is     literate                   illiterate 
Witness name, signature and date are required on this form only when the consenting participant is 
illiterate/not able to read. 
____________________ 
Participant name (print) 
____________________  ________________________ ________________       
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10.2. Data Collection Sheet  
 
Comparability of an innovative Doppler ultrasound fetal heart rate 
monitor to a Pinard fetal stethoscope using cardiotocography as a standard 
to assess the fetal heart rate in singleton pregnancies during labour at 





 SECTION 1: DEMOGRAPHICS AND SOCIAL HISTORY  
1.1 Participant folder number: 
       
 
1.2 Date of birth (DD-MM-YY)  
-             -  
 
1.3 Gravida   
1.4 Parity   
1.5 Weight  (kg)  
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1.7 Gestation age (weeks): Enter on response 1 = early ultrasound 
(<24weeks), 2 = Late ultrasound (>24weeks, 3 = Last menstrual 
period (LMP), 4 = Booking symphysis fundal height  
 
1.8 Marital status: Enter 1=Single, 2=married, 3=divorced, 4= 
widowed 
 
1.9 Employment history: Enter 1 = employed, 2 = unemployed, 3 = 
self- employment 
 
 2. SUBSTANCE USE 
Enter 1= Yes, 2 = No 
 
2.1 Smoking  
2.2 Alcohol  
2.3 Other substances  
 3.  MEDICAL HISTORY:  
Enter 1=Yes or 2=No 
 
3.1 Hypertension  
3.2 Diabetes mellitus  
3.3 Thyroid disease  
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3.5 Asthma  
3.6 Epilepsy  
 4. OBSTETRIC RISK FACTORS:  
Enter 1=Yes or 2=No 
 
4.1 Previous Caeserian section   
4.2 Gestational Hypertension  
4.3 Pre- eclampsia  
4.4 Chronic hypertension  
4.5 Postdate pregnancy/prolonged pregnancy  
4.6 Prolonged rupture of membranes (>24hours)  
4.6 Intrauterine growth restriction (IUGR)/small for gestational 
age (SGA) 
 
   5. LABOUR HISTORY: Enter 1 = spontaneous, 2 = induced 
If 1, jump to Q#6, if 2 enter 1= Yes, 2=No for 5.1 – 5.6 
 
5.1 Prolonged rupture of membrane  
5.2 Pre-eclampsia  
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5.4 Chronic hypertension  
5.5 Gestational diabetes (GDM)/Impaired Glucose Tolerance 
(IGT) 
 
5.6 IUGR/SGA  
5.7 Postdate pregnancy/Prolonged pregnancy  
5.8 Oligohydramnios  
 6. AUGMENTATION OF LABOUR: Enter 1=Yes or 2=No  
6.1 Artificial rupture of membranes  
6.2 Oxytocin use  
 7. FETAL HEART RATE MEASUREMENTS  
7.1a Cervical dilatation at time of fetal heart rate (FHR) 
measurement (cm) 
 
7.1b Awaiting Caesarian section 
Enter 1 = yes, 2 = No 
 
 7.2a. FHR MEASUREMENTS BEFORE FIRST 
CONTRACTION: Beats/min (bpm) 
 
7.2a1 FHR with Cardiotocograph (at beginning of FHR 











Page | 76  
 
7.2a2 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
beginning of FHR measurement by PFS): 
 
7.2a3 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds):  
 
7.2a4 FHR with Cardiotocograph (at the end of FHR measurement 
with PFS)  
 
7.2a5 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
the end of FHR measurement by PFS): 
 
7.2a6 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds): enter same FHR as in 7.2a3 
 
 7.2b. FHR MEASUREMENTS AFTER FIRST 
CONTRACTION: Beats/min (bpm) 
 
7.2b1 FHR with Cardiotocograph (at beginning of FHR 
measurement by PFS) 
 
7.2b2 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
beginning of FHR measurement by PFS):  
 
7.2b3 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds) :  
 










Page | 77  
 
with PFS) 
7.2b5 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
the end of FHR measurement by PFS): 
 
7.2b6 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds): enter same FHR as in 7.2b3  
 
 7.2c. CTG FEATURES (NICE Guidelines as in table 1) at 
time of FHR MEASUREMENTS IN 7.2a AND 7.2b 
Enter 1=reassuring, 2= non-reassuring, 3 = abnormal 
 
7.2c1 Baseline Fetal heart rate (FHR)  
7.2c2 Variability   
7.2c3 Accelerations  
7.2c4 Deceleration   
7.2d CTG CATEGORY (NICE guidelines as in table 2) 
Enter 1 = Normal, 2 = suspicious, 3 = pathological 
 
 7.2e. FHR MEASUREMENTS BEFORE SECOND 
CONTRACTION: Beats/min (bpm) 
 
7.2e1 FHR with Cardiotocograph (at beginning of FHR 
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7.2e2 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
beginning of FHR measurement by PFS):  
 
7.2e3 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds) :  
 
7.2e4 FHR with Cardiotocograph (at the end of FHR measurement 
with PFS) 
 
7.2e5 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
the end of FHR measurement by PFS): 
 
7.2e6 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds): enter same FHR as in 7.2e3 
 
 7.2f. FHR MEASUREMENTS AFTER SECOND 
CONTRACTION: Beats/min (bpm) 
 
7.2f1 FHR with Cardiotocograph (at beginning of FHR 
measurement by PFS) 
 
7.2f2 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
beginning of FHR measurement by PFS):  
 
7.2f3 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds) :  
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with PFS) 
7.2f5 FHR with Doppler Ultrasound FHR monitor (DUFHRM) (at 
the end of FHR measurement by PFS): 
 
7.2f6 FHR with Pinard Fetal stethoscope (PFS) (taken in 
60seconds): enter same FHR as in 7.2f3 
 
 7.2g. CTG FEATURES (NICE Guidelines as in table 1) at 
time of FHR MEASUREMENTS IN 7.2a AND 7.2b 
Enter 1=reassuring, 2= non-reassuring, 3 = abnormal 
 
7.2g1 Baseline Fetal heart rate (FHR)  
7.2g2 Variability  
7.2g3 Accelerations  
7.2g4 Deceleration   
7.2h CTG CATEGORY (NICE guidelines as in table 2) 
Enter 1 = Normal, 2 = suspicious, 3 = pathological 
 
8 Mode of delivery: Enter 1 = Normal vaginal delivery (NVD), 2 
= Caeserian section, 3 = Vacuum extraction, 4 = Forceps delivery 
 
 9. PREGNANCY OUTCOME  
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9.2 Apgar score at 1 min:   
9.3 Apgar score at 5 min:   
9.4 Admission to neonatal care unit: enter 1 = Yes, 2 = No   
9.5 Neonatal resuscitation required: enter 1 = Yes, 2 = No  
9.6 Neonate alive on discharge from hospital: enter 1 = Yes, 
 2 = No 
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Reassuring 110-160 ≥ 5 None Present 
Non-reassuring 100-109 
161-180 




over 50% of 
contractions, 
occurring for over 90 
minutes 
Single prolonged 
deceleration for up to 
3 minutes 





is of uncertain 
significance 










over 50% of 
contractions or late 
decelerations, both 
for over 30 minutes 
Single prolonged 
deceleration for more 
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Table 2: Definition of Normal, Suspicious and Pathological CTG traces 
Category Definition 
Normal  A FHR trace in which all four features are classified as reassuring 
Suspicious A FHR trace with one feature classified as non-reassuring and the 
remaining features classified as reassuring 
Pathological  A FHR trace with two or more features classified as non-reassuring 
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10.3 The three fetal heart rate monitoring devices 
Comparability of an innovative Doppler ultrasound fetal heart rate 
monitor to a Pinard fetal stethoscope using a cardiotocography as a 
standard fetal heart rate monitor to assess the fetal heart rate pattern of 
singleton pregnancies during labour at Mowbray Maternity Hospital 
 
A: Pinard Fetal stethoscope (PFS): cone shaped device used to measure fetal 
heart rate  
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B: Doppler Ultrasound Fetal Heart Rate Monitor (DUFHRM): Portable 
electronic device that displays fetal heart rate   
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C: Cardiotocograph (CTG): electronic device that provides a continuous 
visual and printed record of the fetal heart rate and uterine contractions 
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10.4. The Standard operating procedures (SOP) 
 
Comparability of an innovative Doppler ultrasound fetal heart rate 
monitor to a Pinard fetal stethoscope using cardiotocography as a standard 
to assess the fetal heart rate in singleton pregnancies during labour at 
Mowbray Maternity Hospital 
 
SOP No. 1   
Title: SOP for Eligibility Determination, recruitment and enrollment 
Original Effective Date: 12 May 2012  Revision Effective Date: Not Applicable 
 
Purpose 
To define eligibility determination procedures for the study  
Scope 
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Responsibilities 
The study staff who performs eligibility determination, recruitment and 
enrollment procedures, and measurements and documentation for the study 
is responsible for understanding and following this SOP. 
Procedures 
 




a. Women with singleton pregnancies in the active phase of the first 
stage of labour undergoing continuous CTG monitoring 
 
b. Women with singleton pregnancies in the active phase of the first 
stage of labour and awaiting an emergency caesarean section for 
any indications e.g. failure to progress, failed vaginal birth after 
caesarean section 
 
















a. Women with multiple pregnancies 
 
b. Women in labour with an intrauterine fetal death or not requiring 
monitoring as assessed by the attending doctor (e.g. in very 
preterm labour with a gestational age below 28 completed weeks, 
severe fetal anomalies) 
 
c. Inability or unwillingness of participant to give written informed 
consent 
 
d. Women who withdraw informed consent at any time during the 
study 
 
e. Women requiring caesarean section for an indication that is so 
urgent that it cannot delay 
 
 Eligibility Determination / Screening  
 
1. Review potential study participant’s folder on admission or in 










Page | 89  
 
 
2. Approach potential participant and determine ability and 
willingness to provide a written informed consent if meets other 
inclusion criteria. 
 
3. Administer a written informed consent. 
 
4. If consent obtained, document the participant’s name and folder 
number on the name link log. 
 
5. Proceed to completing the data collection sheet and organize the 
setting for FHR measurements using the three fetal heart rate 
monitoring devices. 
 
 Socio-demographic, medical and past medical history  
 
1. Social, demographic, medical history information data will be 
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2. Where more information is needed on the above, the investigator 
will interview the participant to obtain the required information. 
 Measurements 
1. Identify area on the patient’s abdomen where the FHR is easiest 
picked up by the observers with Pinard fetal stethoscope (PFS) and 
mark this area. Identify with the Innovative Doppler Ultrasound 
monitor with another area on the patient’s abdomen, where the 
Innovative Doppler Ultrasound monitor (DUFHRM) can pick up 
the fetal heart rate and mark the point upon obtaining verbal 
consent from the patient.  
 
2. Palpation for a contraction will then be done, once absence of 
contraction is confirmed, proceed as below: 
 
a. The observer with a PFS measures the FHR (i.e. counts the 
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b. The second observer notes the FHR on the DUFHRM at the 
start and at the end of the PFS measurement (i.e. at the start 
and at the end of the 60 second period). The third observer also 
notes the FHR on the CTG at the same time point (i.e. at the 
beginning of counting FHR with PFS and at the end of the PFS 
measurement). 
 
c. To ensure that the measurements above are taken at the 
appropriate time, the observer using the PFS will signal to the 
other 2 observers when she starts counting the FHR and when 
she finishes counting. 
 
d. The measurements in 2a, 2b and 2c will then be recorded on 
the data collection sheet. 
 
 
3. A contraction will then be palpated again. 30 seconds after the 
palpable contraction ends, proceed as in 2a, 2b and 2c above and 
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4. Before the next contraction, proceed again as in 2 and 3 above. The 
observers using the PFS and DUFHRM will swap the devices at the 
measurements before and after the second contraction 
 
 
 Mode of delivery and Neonatal outcomes 
 
Mode of delivery and neonatal outcomes will be extracted from the 
patient’s file once this information becomes available 
 









_________________________                                                             __________ 
Lameck Chinula, MBBS                                                                                Date 
Principal Investigator 
 
